Replies to post #162971 on Cytodyn Inc (CYDY)

[misiu143]

Ibalizumab was approved with 40 patients and 43% efficacy in 25 weeks study IV Infusion ..with some side effects ..
one or two years ago

Cydy finished in 2018 , with 52 patients 25 weeks study SC injection , and no serious side effects ..

I remember facts ,